(IN BRIEF) The European Commission has approved AstraZeneca’s Imfinzi (durvalumab) combined with gemcitabine and cisplatin as neoadjuvant therapy, followed by Imfinzi adjuvant monotherapy, for adults with resectable muscle-invasive bladder cancer. This approval is anchored in NIAGARA Phase III trial data … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged adjuvant monotherapy, AstraZeneca, cisplatin, curative intent, Dave Fredrickson, durvalumab, ESMO, European Commission, event-free survival, gemcitabine, Imfinzi, immunotherapy, MIBC, Michiel Van der Heijden, muscle-invasive bladder cancer, neoadjuvant chemotherapy, New England Journal of Medicine, NIAGARA Phase III, NMIBC, overall survival, radical cystectomy
Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with uncontrolled asthma, irrespective of minimum baseline eosinophil levels or other biomarkers of Type 2 inflammation Greater … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged asthma, corticosteroids, Dupixent, New England Journal of Medicine, Sanofi
Clinicians at the University Hospital Erlangen show how a new laser-based imaging technique termed MSOT can detect inflammation more accurately than current non-invasive diagnostic procedures and thereby help reduce the burden to patients MUNICH, 30-Mar-2017 — /EuropaWire/ — Ulcerative colitis … Read the full press release
Posted in France, Germany, Healthcare, Italy, Netherlands, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Christian Wiest, Clinicians, Crohn's disease, Crohn's disease patients, detection of melanoma metastasis, diagnosis, diagnostic imaging, Dr. Ferdinand Knieling, hemoglobin values, IBD, inflammation, inflammatory bowel disease, intestinal mucosa, invasive endoscopy procedure, iThera Medical, laser light, laser-based imaging technique, medical device, medical imaging, MSOT, MSOT technology, Multspectral Optoacoustic Tomography, new diagnostic imaging modality, New England Journal of Medicine, non-invasive assessment, optoacoustic, optoacoustic imaging, photoacoustic, Prof. Dr. Maximilian Waldner, sentinel lymph nodes, suspicious breast lesions, Ulcerative colitis, ultrasound, University Hospital Erlangen
– The highest burden of dengue disease globally in endemic countries is in pre-adolescent to adults age group[1],[2],[3] – In a new pooled analysis, dengue vaccine candidate protected two out of three volunteers aged 9 years and older against all four … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged Dengue Vaccine, Dr. Maria Rosario, New England Journal of Medicine, Sanofi Pasteur
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?